CONFIDENTIAL TREATMENT DEVELOPMENT AND SUPPLY AGREEMENTConfidential Treatment • August 9th, 2006 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • Illinois
This Agreement is made this third day of April, 2000 (“Effective Date”) by and between Cubist Pharmaceuticals, Inc., having a principal place of business at 24 Emily Street, Cambridge, Massachusetts 02139 (hereinafter referred to as “Cubist”) and Abbott Laboratories, having a principal place of business at 100 Abbott Park Road, Abbott Park, Illinois 60064-3500 (U.S.A.) (hereinafter referred to as “Abbott”).
CONFIDENTIAL TREATMENT FIRST AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENTDevelopment and Supply Agreement • August 9th, 2006 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations
THIS FIRST AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (this “First Amendment”) is entered into as of the 1st day of June 2006 by and between Cubist Pharmaceuticals, Inc., a Delaware corporation (“Cubist”) and Hospira Worldwide, Inc., a Delaware corporation (“Hospira”) to amend the terms of that certain Development and Supply Agreement dated the third day of April, 2000 between Abbott Laboratories, predecessor in interest to Hospira, and Cubist (the “Agreement”).
